Autoantibody Profiles Reveal Ubiquilin 1 as a Humoral Immune Response Target in Lung Adenocarcinoma
Open Access
- 1 April 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 67 (7), 3461-3467
- https://doi.org/10.1158/0008-5472.can-06-4475
Abstract
There is considerable evidence that the presence of cancer can elicit a humoral immune response to specific proteins in the host, and these resulting autoantibodies may have potential as noninvasive biomarkers. To characterize the autoantibody repertoire present in the sera of patients with lung adenocarcinoma, we developed a high-density peptide microarray derived from biopanning a lung cancer phage display library. Using a 2,304-element microarray, we interrogated a total of 250 sera from Michigan lung cancer patients and noncancer controls to develop an “autoantibody profile” of lung adenocarcinoma. A set of 22 discriminating peptides derived from a training set of 125 serum samples from lung adenocarcinoma patients and control subjects was found to predict cancer status with 85% sensitivity and 86% specificity in an independent test set of 125 sera. Sequencing of the immunoreactive phage-peptide clones identified candidate humoral immune response targets in lung adenocarcinoma, including ubiquilin 1, a protein that regulates the degradation of several ubiquitin-dependent proteasome substrates. An independent validation set of 122 serum samples from Pittsburgh was examined using two overlapping clones of ubiquilin 1 that showed 0.79 and 0.74 of the area under the receiver operating characteristics curve, respectively. Significantly increased levels of both ubiquilin 1 mRNA and protein, as well as reduced levels of the phosphorylated form of this protein, were detected in lung tumors. Immunofluorescence using anti–ubiquilin 1 antibodies confirmed intracellular expression within tumors cells. These studies indicate that autoantibody profiles, as well as individual candidates, may be useful for the noninvasive detection of lung adenocarcinoma. [Cancer Res 2007;67(7):3461–7]Keywords
Other Versions
This publication has 47 references indexed in Scilit:
- Ubiquilin 1 Modulates Amyloid Precursor Protein Trafficking and Aβ SecretionPublished by Elsevier BV ,2006
- Interaction between Presenilin 1 and Ubiquilin 1 as Detected by Fluorescence Lifetime Imaging Microscopy and a High-throughput Fluorescent Plate ReaderPublished by Elsevier BV ,2006
- Autoantibodies to Annexin XI-A and Other Autoantigens in the Diagnosis of Breast CancerCancer Research, 2004
- Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survivalCancer, 2004
- Humoral Immune Response to -Methylacyl-CoA Racemase and Prostate CancerJNCI Journal of the National Cancer Institute, 2004
- Identification of circulating antibodies to tumor‐associated proteins for combined use as markers of non‐small cell lung cancerProteomics, 2004
- Early Detection of Lung Cancer Using Serum RNA or DNA Markers: Ready for “Prime Time” or for Validation?Journal of Clinical Oncology, 2003
- AACR Special Conference in cancer research: ubiquitination in normal and cancer cellsExpert Opinion on Biological Therapy, 2003
- Gene-expression profiles predict survival of patients with lung adenocarcinomaNature Medicine, 2002
- A Paradigm for Class Prediction Using Gene Expression ProfilesJournal of Computational Biology, 2002